1252780-72-5

Trifluoroacetyl Piperazine is used to prepare thienopyrimidine-based P2Y12 platelet aggregation inhibitors. It can also be used as a reagent to synthesize orally efficacious tetrahydropyridopyridazinone PARP inhibitors for the treatment of cancer.